Format

Send to

Choose Destination
Bioorg Med Chem. 2007 May 15;15(10):3321-33. Epub 2007 Mar 12.

Further modification on phenyl acetic acid based quinolines as liver X receptor modulators.

Author information

1
Chemical and Screening Sciences, Wyeth Pharmaceuticals, 500 Arcola Road, Collegeville, PA 19426, USA. hub@wyeth.com

Abstract

A series of phenyl acetic acid based quinolines was prepared as LXR modulators. An SAR study in which the C-3 and C-8 positions of the quinoline core were varied led to the identification of two potent LXR agonists 23 and 27. Both compounds displayed good binding affinity for LXRbeta and LXRalpha, and increased expression of ABCA1 in THP-1 cells. These two compounds also had desirable pharmacokinetic profiles in mice and displayed in vivo efficacy in a 12-week Apo E knockout mouse lesion model.

PMID:
17391964
DOI:
10.1016/j.bmc.2007.03.013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center